Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DYRK1A (clone 9QG35L1G). We employs the AAV (T7-Cy3-NF-κB-BamHI) vector components and the SynExpress system of the Histone modification sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DYRK1A
Clone
9QG35L1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
NF-κB
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.92
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.